Research into conolidine has led to discovery of an opioid receptor in the human body termed ACKR3/CXCR7. ACKR3 appears to be probably the most desired target for conolidine, which also disregards one other 4 classical opioid receptors(3). There is certainly fascination in applying conolidine like a pain-reliever according to https://sitesrow.com/story10315686/how-much-you-need-to-expect-you-ll-pay-for-a-good-conolidin-to-replace-traditional-painkillers